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Background: DNA methyltransferase 1 (Dnmt1) regulates expression of many critical genes through maintaining
parental DNA methylation patterns on daughter DNA strands during mitosis. It is essential for embryonic
development and diverse biological processes, including maintenance of hematopoietic stem and progenitor cells
(HSPCs). However, the precise molecular mechanism of how Dnmt1 is involved in HSPC maintenance remains
unexplored.
Methods: An N-ethyl-N-nitrosourea (ENU)-based genetic screening was performed to identify putative mutants
with defects in definitive HSPCs during hematopoiesis in zebrafish. The expression of hematopoietic markers
was analyzed via whole mount in situ hybridization assay (WISH). Positional cloning approach was carried out
to identify the gene responsible for the defective definitive hematopoiesis in the mutants. Analyses of the
mechanism were conducted by morpholino-mediated gene knockdown, mRNA injection rescue assays, anti-
phosphorylated histone H3 (pH3) immunostaining and TUNEL assay, quantitative real-time PCR, and bisulfite
sequencing analysis.
Results: A heritable mutant line with impaired HSPCs of definitive hematopoiesis was identified. Positional
cloning demonstrated that a stop codon mutation was introduced in dnmt1 which resulted in a predicted
truncated Dnmt1 lacking the DNA methylation catalytic domain. Molecular analysis revealed that expression of
CCAAT/enhancer-binding protein alpha (C/ebpa) was upregulated, which correlated with hypomethylation of
CpG islands in the regulation regions of cebpa gene in Dnmt1 deficient HSPCs. Overexpression of a
transcriptional repressive SUMO-C/ebpa fusion protein could rescue hematological defects in the dnmt1
mutants. Finally, dnmt1 and cebpa double null embryos exhibited no obvious abnormal hematopoiesis
indicated that the HSPC defects triggered by dnmt1 mutation were C/ebpa dependent.
Conclusions: Dnmt1 is required for HSPC maintenance via cebpa regulation during definitive hematopoiesis
in zebrafish.
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In vertebrates, hematopoiesis takes place in two consecu-
tive waves, primitive and definitive ones [1,2]. Primitive
hematopoiesis, also known as embryonic hematopoiesis,
predominantly produces erythroid and myeloid cells [3,4];
while definitive hematopoiesis, also called adult hemato-
poietic wave, generates hematopoietic stem cells (HSCs)
that are capable of producing all lineages of blood [5]. The
zebrafish (Daniorerio) is an excellent genetic system for
the study of hematopoietic development [6,7], especially
by characterization of thousands of mutants isolated from
large-scale forward genetic screens [8,9]. In zebrafish, de-
finitive HSCs arise from the ventral wall of the dorsal aorta
(VDA), the zebrafish equivalent of the aorta/gonad/meso-
nephros (AGM) of mammals [10,11], then HSCs migrate
through the caudal hematopoietic tissue (CHT) to the thy-
mus and kidney marrow [12], where adult hematopoiesis
occurs, similar to HSC migration through fetal liver and
home to bone marrow in mammals.
The molecular regulation of hematopoiesis includes
interactions of lineage-specific transcription factors and
a series of epigenetic modifications, such as DNA
methylation and covalent histone tail modifications [13].
DNA methylation is an important epigenetic regulation
mechanism that regulates normal development through
influencing gene transcription, genomic imprinting, and
genome stability in mammal cells [14-16]. In hematologic
malignancies, dysregulation of DNA methylation may
result in global shifts in gene expression, which frequently
leads to increased self-renewal in malignant blood cells at
the expense of normal differentiation [17].
Three active DNMTs, namely DNMT1 [18], DNMT3A,
and DNMT3B [19,20], have been identified in mammals.
DNMTs are highly evolutionarily conserved with a regula-
tory region attached to a catalytic domain [21]. DNMT1 is
the most abundant DNA methyltransferase in mammalian
cells and considered to be the key maintenance methyl-
transferase [22]. In mammals, DNMT1 null mutant
embryonic stem cells are viable and contain a small per-
centage of methylated DNA and methyltransferase activity
[23]. Mouse embryos homozygous for a deletion of Dnmt1
die at 10 to 11 days gestation due to development defects
[24]. Reduced Dnmt1 activity in xenopus [25] and zebra-
fish [26,27] has similar consequences. Dnmt1 also plays
important roles in HSPCs. The deletion of Dnmt1 has no
influence on the mature cells in the hematopoietic system
but causes decreased niche retention and self-renewal and
differentiation defects of HSPCs [28]. In acute myeloid
leukemia (AML), the expression of DNMTs is upregulated
[29]. Conditional knockout of Dnmt1 blocks development
of leukemia, and haploinsufficiency of Dnmt1 is sufficient
to delay progression of leukemogenesis and impair
leukemia stem cell (LSC) self-renewal without altering
normal hematopoiesis [30]. The precise mechanism of theDnmt1 regulation of HSC function requires further
investigation.
In this study, a heritable zebrafish mutant line with
hematopoietic defects identified through ENU-based for-
ward genetic screening was found defective in dnmt1
gene. Phenotype characterization of dnmt1 mutant has
uncovered severely impaired definitive hematopoiesis.
Further molecular mechanistic studies revealed that
cebpa was a Dnmt1 downstream target gene and acti-
vated as a result from hypomethylation of its regulation
regions in dnmt1 mutants, which suggested cebpa was a
key downstream target of dnmt1 gene in HSPCs. We
further demonstrated that the elevated C/ebpa activity
was required and accounted for, at least in part, the
defective definitive hematopoiesis.Results
Zebrafish mutant line ldd794 displays impaired definitive
hematopoiesis
To search for novel genes involved in regulating definitive
hematopoiesis, we established an ENU-based genetic
screening strategy to identify putative mutants with
defects in definitive HSPCs in zebrafish. Whole-mount
mRNA in situ hybridization (WISH) analysis of cmyb [31],
a marker of HSPCs, was used to screen for mutants. In the
mutant line ldd794, cmyb expression in homozygous em-
bryos was reduced from 36 hours post-fertilization (hpf) in
the AGM (Figure 1A, B) and was almost absent at 5 days
post-fertilization (dpf) in the CHT (Figure 1I, J). Similarly,
the expression of two other HSPC markers runx1 as well
as scl were also decreased (Figure 1K-N), suggesting the
definitive HSPCs were impaired. ldd794 heterozygous fish
was crossed with a Tg (cmyb:EGFP) homozygous individual
(a stable zebrafish transgenic line expressing EGFP under
the control of the cmyb promoter) [32]. The adult fishes
carrying both dnmt1 mutant allele and EGFP transgene
were incrossed. As expected, the number of EGFP-positive
cells was significantly decreased in the CHT of approxi-
mate 25% EGFP positive offspring at 4 dpf (Additional
file 1: Figure S1A). This result further confirmed the
HSPCs were specifically affected in ldd794 mutants.
The temporal and spatial expression patterns of a set of
hematopoietic transcription factors and key genes in-
volved in either lineage determination or differentiation
were examined in ldd794 mutants. The expression of
erythrocyte progenitor marker gata1 [33], mature erythro-
cyte marker hbae1 [34], myeloid-specific marker mpx
[35], l-plastin [36] and lysozyme C [37], and lymphoid-
specific marker rag1 [38] were all diminished in ldd794
homozygous mutants (Figure 1O-Z). The decrease of mul-
tiple hematopoietic lineages suggested that the deficiency
of hematopoietic precursors and/or progenitors occurred
in the dnmt1 mutants.
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Figure 1 Impairment of definitive hematopoiesis in dnmt1 mutant zebrafish. (A-J) WISH analysis of cmyb expression from 36 hpf to 5
dpf. In ldd794 mutant, cmyb expression was decreased from 36 hpf (A-B) and absent at 5 dpf (I-J). (K, K’, L, L’) Expression of hematopoietic
progenitor marker runx1 was decreased at 36 hpf. (K’, L’) Magnified images of the boxed regions in K and L, respectively. (M-N) Expression of
hematopoietic progenitor marker scl was decreased at 5 dpf. (O-Z) WISH analysis of key hematopoietic markers in dnmt1 mutant embryos and
wild-type siblings. Expression of erythrocyte progenitor marker gata1 (O-P), mature erythrocyte marker hbae1 (Q, R), myeloid-specific marker
mpx (S, T), macrophage marker lyz (U, V), l-plastin (W, X) were decreased. Expression of lymphocyte maker rag1 (Y, Y’, Z, Z’) was completely
absent at 4 dpf. Blue arrows indicate the position of the thymus; red arrows indicate the CHT; black arrows indicate the AGM.
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hematopoiesis was due to the preexisting primitive
hematopoietic defects in ldd794 mutants, a series of
markers involved in primitive hematopoiesis, such as
scl, hbae1, pu.1, mpx, and lysozyme C were also exam-
ined at 22 hpf. No overt changes have been detected
(Additional file 1: Figure S1B), suggesting that primitive
hematopoiesis was not affected in the dnmt1 mutants.
Since normal vasculogenesis is required for the birth
of HSCs from the ventral wall of the dorsal aorta in the
zebrafish embryo [10,11,39,40], we evaluated early vascu-
lar development by expression of vascular markers. No
obvious differences in flk1 and ephrinB2 expressions
were observed between ldd794 siblings and mutants
(Additional file 1: Figure S1C), suggesting that the vas-
cular system and artery-vein differentiation remained
intact and the hematopoiesis defects were not due to
impaired vasculature.
Zebrafish ldd794 mutant encodes a truncated Dnmt1
lacking the enzymatic catalytic domain
Positional cloning approach was applied to identify the
gene responsible for the defective definitive hematopoiesis
in ldd794 mutants. Bulk segregation analysis indicated that
the potential mutation site was located on chromosome 3.
The 528 putative mutant embryos (1,056 meioses) were
further examined. Seven homologous recombinations of
sslp1 (zC250L3) and eight homologous recombinations of
sslp2 (zC74M13) from different embryos were identified,
which enabled us to localize the mutation to a 0.45-MB
region containing eight genes (Figure 2A). Complementary
DNA (cDNA) sequencing of all eight candidate genes re-
vealed that in dnmt1, there was a T to A transversion,
which introduced a stop codon at 743th amino acid,
resulting in a predicted truncated Dnmt1 lacking the DNA
methylation catalytic domain (Figure 2B-D). The gene syn-
teny analysis revealed that Dnmt1 genomic context was
highly conserved from zebrafish to human (Figure 2E).
Loss of Dnmt1 catalytic activity leads to specific HSPC
defects
WISH analysis revealed that zebrafish dnmt1 was
expressed ubiquitously, including the hematopoietic re-
gions (Additional file 1: Figure S2). The dnmt1 specific
antisense ATG-morpholino (MO) was injected into wild-type embryos at one-cell stage to reproduce the pheno-
types observed in ldd794 mutant embryos. As expected,
the expression of cmyb diminished from 36 hpf (Figure 3B,
B’) in the AGM and significantly reduced in the CHT at 5
dpf (Figure 3F, F’), which was exactly a phenocopy of
ldd794 mutants. Unsurprisingly, erythrocytes, myeloid
cells, and lymphocytes were decreased in dnmt1 ATG
morphants (Additional file 1: Figure S3). Furthermore, a
dnmt1 splicing MO, specifically affecting splicing of pre-
cursor dnmt1 RNA transcripts (Additional file 1: Figure
S4), was also able to mimic the Dnmt1 protein truncation
identified in ldd794 mutants. A similar effect to that of
ATG MO was observed (Figure 3C, C’, G, G’), further con-
firming that the loss of Dnmt1 catalytic activity indeed spe-
cifically led to observed HSPC defects in the dnmt1
mutants.
Finally, specific in vivo rescue experiments were car-
ried out. Full-length zebrafish dnmt1 mRNA was co-
injected with dnmt1 ATG MO into wild-type embryos.
The results showed that dnmt1 mRNA could efficiently
rescue the hematopoietic defects in dnmt1 morphants
(Figure 3D, D’, H, H’). In contrast, co-injection of the
truncated dnmt1 mutant mRNA with the dnmt1 ATG
MO was ineffective (data not shown). Consistently,
dnmt1 mRNA could also restore the defects of HSPCs
in ldd794 mutant embryos (Figure 3I-N). These data
demonstrated that the phenotype observed in dnmt1
mutants was indeed Dnmt1 dependent.
To investigate whether the observed deficient Dnmt1-
mediated phenotypes were due to abnormal cell prolifera-
tion or apoptosis of definitive HSPCs, the anti-
phosphorylated histone H3 (pH3) immunostaining and
TUNEL assay were performed, respectively. A decrease of
pH3 and cmyb-EGFP double positive cells was detected
while no obvious change of TUNEL and cmyb-EGFP
double positive cells was found in dnmt1 mutants
(Figure 3O-U, Additional file 1: Figure S5). Similar results
were observed in dnmt1 morphants (data not shown), sug-
gesting that the defects of HSPCs in dnmt1-deficient
embryos were caused by decreased proliferation.
Increased cebpa expression was correlated with
hypomethylation of CpG islands
Given the fact that Dnmt1 predominantly methylates
hemimethylated CpG dinucleotides in the mammalian
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Figure 2 The phenotype of hematopoietic defects is caused by mutation in dnmt1. (A) Genetic mapping of ldd794 on chromosome 3. The
numbers above the SSLP markers indicate the number of recombinants in 1,056 meioses analyzed. Fine mapping using SSLPs narrowed down
the region between sslp1 and sslp2 markers. The red asterisk indicates the mutation position within dnmt1 gene. (B) Sequence traces of pooled
sibling and pooled dnmt1 mutant cDNAs. A T to A transversion at 2,229th nucleotide resulted in a stop codon in dnmt1 (marked by red asterisk).
(C) Sequence result of grandparents. The sequence result indicated that this pair of ldd794 mutants (screened out in ENU project) was
heterozygote carrying one mutated allele of dnmt1 (marked by red asterisk). (D) Structure of wild-type and mutant Dnmt1 protein. (E) Synteny
analysis of dnmt1.
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we speculate that the loss of Dnmt1 might activate some
key negative regulators of definitive hematopoiesis.
C/ebpa, a member of the basic leucine zipper protein
family of transcription factors [41,42], not only plays a piv-
otal role in granulopoiesis [43] but also regulates the self-
renewal and proliferation of HSPCs at a much earlier
stage during mouse hematopoiesis [44-47]. C/ebpa defi-
ciency leads to hyperproliferation and increased self-
renewal capacity in both fetal and adult HSCs [44,45,47],
while activation of C/ebpa is sufficient to repress stem cell
capacities and proliferation of HSCs [46]. More direct evi-
dence is that C/EBPa has previously been reported as acell-cycle inhibitor [48]. These evidences prompted us to
test whether C/ebpa function was important for mediating
the observed HSPC proliferation phenotypes in the dnmt1
mutants.
Firstly, to test whether cebpa was upregulated in
dnmt1-deficient HSPCs, dnmt1 MO was injected into
Tg (cmyb:EGFP) embryos at one-cell stage, then cmyb-
EGFP positive cells were sorted and collected at 3 dpf
(Figure 4A). RT-PCR results showed that the expres-
sion of cebpa indeed increased in dnmt1-deficient
cmyb-EGFP positive cells (Figure 4B).
Secondly, we checked the DNA methylation status of
the CpG islands located near the zebrafish cebpa gene.
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Figure 3 Dnmt1 mRNA rescue and anti-phosphorylated histone H3 (pH3) immunostaining assays in dnmt1-deficient embryos.
(A-H) Dnmt1 mRNA rescue assay at 36 hpf (A-D) and 5 dpf (E-H). Dnmt1 ATG morpholino (4 ng) and splicing-specific morpholino (8 ng)
effectively reproduced decreased cmyb expression phenotype in wild-type embryos (B, C, F, G). Dnmt1 mRNA rescued the defects of dnmt1
morphants. (I-N) Rescue assay of wild-type dnmt1 mRNA in ldd794 dnmt1 mutants at 36 hpf (I-K) and 3 dpf (L-N). Wild-type dnmt1 mRNA
effectively restored cmyb expression in ldd794 dnmt1 mutants at 36 hpf (K) and 3 dpf (N). (A’-N’) Magnified images of the boxed regions in A
to N, respectively. Red arrows indicate cmyb-positive HSPCs in the AGM or CHT. (O-T) The proliferation of HSPCs was reduced in dnmt1−/−
mutants. Double immunostaining of cmyb-EGFP (O-P) and anti-PH3 (Q-R) in the CHT of Tg(cmyb-EGFP) line at 72 hpf. The bottom panel
shows merged images (S, T). (U) Statistics of PH3 and cmyb-EGFP double positive cells.
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the downstream genomic sequence of the zebrafish
cebpa gene were searched for potential CpG islands. A
total of 14 candidate CpG islands were found, and their
DNA methylation statuses were evaluated by bisulfite se-
quencing analysis. The hypermethylation was found in
four CpG island regions (BSP1 to BSP4) near the cebpa
gene in wild-type cmyb-EGFP positive cells. As expected,
a much lower methylation status was found in these four
CpG islands in MO-injected cmyb-EGFP positive cells
(Figure 4C, Additional file 1: Figure S6). Taken together,
cebpa expression is likely regulated by Dnmt1 activity.
Cebpa upregulation was involved in the defective HSPC
phenotypes in dnmt1-deficient embryos
A series of rescue assays were carried out in order to
verify whether elevated expression of cebpa is respon-
sible for dnmt1 mutant phenotype. In our previous
work, two repressive forms of C/ebpa have been con-
structed [49], SUMO2-C/ebpa, mimicking the constitu-
tively sumoylated form of C/ebpa and POZ-C/ebpa,
mimicking the SUMO-mediated repressive form. The
mRNAs of these two constructs were individually
injected into the wild-type embryos with dnmt1 ATGMO, respectively. Both were shown to be effective in
rescuing cmyb expression (Figure 5A-H) in the mor-
phants. The similar rescuing results were also observed
in ldd794 mutant embryos overexpressing SUMO2-C/
ebpa repressive protein (Figure 5I-N).
It is worth noting that two dnmt1 mutant lines with
liver and pancreas development defects were reported
[50]. As expected, the similar phenotypes were also
detected in our ldd794 mutants by assessing the expres-
sion of hepatocytes marker lfabp and pancreas marker
trypsin (Additional file 1: Figure S7). Intriguingly, the
rescue effects of SUMO2-C/ebpa on liver and pancreas
development defects were not observed (Additional file
1: Figure S7), suggesting the role of Dnmt1 in liver and
pancreas development was unlikely cebpa dependent.
Taken together, these data strongly suggest that elevated
cebpa function is involved in HSPC defects of dnmt1
mutants.
Cebpa function was pivotal to Dnmt1 regulated
maintenance of definitive HSPCs
We have generated a cebpa null mutant zebrafish line by
TALEN approach (submitted elsewhere). The phenotype
was similar to that observed in mice. While no mature
18/20 
21/28 36hpf
36hpf 19/21
22/26
21/2836hpf
W
T
dn
m
t1
 M
O
dn
m
t1
M
O
+
po
z-
ce
bp
ad
nm
t1
M
O
+
s2
-c
eb
pa
11/12 
5dpf
5dpf
5dpf
5dpf
cmyb
A E
B F
C G
D H
A’
B’
C’
D’
E’
F’
G’
H’
Sibling
36hpf 36hpf 36hpf
dnmt1-/ - dnmt1-/ - + s2-cebpa mRNA
cm
yb
3dpf 3dpf 3dpf
I J K
L M N
I’ J’ K’
L’ M’ N’
Figure 5 SUMO2-C/ebpa, POZ-C/ebpa rescue assay in dnmt1 morphants and ldd794 dnmt1 mutants. (A-H) SUMO2-C/ebpa and POZ-C/
ebpa restored cmyb expression in dnmt1 MO knockdown morphants at 36 hpf (A-D) and 5 dpf (E-H). (I-N) SUMO2-C/ebpa mRNA restored cmyb
expression in the AGM region at 36 hpf (K) and the CHT region at 3 dpf (N) of ldd794 dnmt1 mutants. (A’-N’) Magnified images of the boxed
regions in A to N. Red arrows indicate cmyb-positive HSPCs in the AGM or CHT.
Liu et al. Journal of Hematology & Oncology  (2015) 8:15 Page 8 of 12myelocytes were detected by Sudan Black staining, the ex-
pression of cmyb remained unchanged, if not a marginal in-
crease. This cebpa mutant line was then crossed with
ldd794 heterozygotes. The adult fishes carrying both cebpa
and dnmt1 mutant alleles were incrossed. We found only
in the presence of C/ebpa that cmyb expression was se-
verely decreased (Figure 6B, B’). By contrast, in the cebpa
and dnmt1 double null mutants, the expression level of
cmyb remained normal (Figure 6D, D’). In parallel, similar
results were observed in cebpa null embryos knocked down
with dnmt1MO (Additional file 1: Figure S8). These results
indicate that the defective HSPCs triggered by dnmt1
mutation require intact C/ebpa function. Therefore, cebpa
is a key target gene of dnmt1 and its regulated function is
involved in the definitive HSPCs maintenance.Discussion
In this study, a zebrafish mutant line with definitive
hematopoiesis defects was identified. The specific
phenotype was caused by a premature termination
codon in the dnmt1 gene, which resulted in a truncated
Dnmt1 protein lacking its catalytic domain. DNMT1
protein is an important DNA methyltransferase to
silence and regulate genes by methylation of DNA
regions without changing the genomic DNA sequence
[23]. Lack of Dnmt1 function resulted HSPC prolifera-
tion block and shortage of differentiated blood lineages.
We demonstrated that normal Dnmt1 function was
critical in regulating cebpa gene expression, and intact
C/ebpa function was required for HSPC proliferation
block triggered by the absence of Dnmt1 function. Our
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Figure 6 WISH assays of cmyb in cebpa null mutants and siblings with or without dnmt1 mutation. (A) WISH assay of cmyb in embryos
without cebpa and dnmt1 homozygote mutation. (B) WISH assay of cmyb in embryos only with dnmt1 homozygote mutation. Note that cmyb
was markedly decreased. (C) WISH assay of cmyb in embryos only with cebpa homozygote mutation. (D) WISH assay of cmyb in embryos both
with cebpa and dnmt1 homozygote mutation. Note that cmyb was comparable with embryos without dnmt1 homozygote mutation.
(A’-D’) Magnified images of the boxed regions in A to D. Red arrows indicate cmyb-positive HSPCs in the CHT.
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downstream target of Dnmt1 in regulating HSPC pro-
liferation during normal hematopoiesis.
Many lines of evidences demonstrate that DNA
methylation influences gene expression during embryo-
genesis [51-53]. In mice, a Dnmt1 mutation led to a
recessive lethal phenotype with stunted and delayed de-
velopment [24]. Similarly, two other zebrafish mutants
related to dnmt1 were shown to have defects in pan-
creas development at a late embryonic stage and
resulted in embryonic lethality [50]. In line with these
mutant phenotypes, our ldd794 homozygous mutants
usually die at 8 dpf with abnormal hematopoiesis and
other organ formation such as the liver, further suggest-
ing that reduced DNA methylation causes developmen-
tal abnormality and embryonic lethality. It is worth
noting that ldd794 heterozygotes do not display any
observable phenotype, implying that the mutated dnmt1
allele does not play a dominant negative role.
Our developmental and molecular analyses showed that
the lack of Dnmt1 enzymatic activity in ldd794
mutants led to severe reduction in HSPC numbers as well
as impaired production of all three major lineages but ac-
companied by normal vascular development during early
development. These observations are in an agreement
with the ones from mouse studies [28]. Bone marrow
transplant assays revealed that Dnmt1 affected HSCs in a
cell-autonomous manner [28]. Our findings, together with
those in mice, demonstrate that Dnmt1 has a conserved
role in definitive hematopoiesis.The phenotype with lower number of HSPCs in CHT
might be due to either reduced proliferation or increased
apoptosis of HSPCs. The pH3 and TUNEL assays sug-
gested that the definitive HSPC defects are not due to
increased apoptosis but likely caused by decreased pro-
liferation of HSPCs. These results are also consistent
with the fact that the frequencies of apoptotic cells in
total BM, CMPs, GMPs, or MEPs remained unchanged
in mouse mutants [28].
Given the fact that C/ebpa is a critical transcription fac-
tor for granulopoiesis [43], we have expected that its acti-
vation might induce accelerated myeloid differentiation.
However, downregulated mpx expression in dnmt1 mu-
tant does not support an increased myeloid differentiation
process. Meanwhile, an increased number of reports have
demonstrated that C/ebpa is an important modulator of
HSPC function [44-47]. Supporting this idea, we have
found that hypomethylation of the cebpa regulatory region
as a result of Dnmt1 deficiency is directly associated with
HSPC impairment. Although the possibility of other
negative regulators being activated cannot be excluded
completely, HSPC proliferation defect caused by dnmt1
mutation is indeed C/ebpa dependent; as in the cebpa/
dnmt1 double null mutants, the cmyb expression ap-
peared to be normal. It was reported that C/EBPa nega-
tively regulated n-myc, and the loss of C/EBPa resulted
in de-repression of n-myc in mice HSCs [47]. Indeed, our
Q-PCR analysis revealed that in cmyb-EGFP positive cells
sorted from dnmt1 MO knockdown embryos, n-myc had
a much lower expression level (data not shown), which
Liu et al. Journal of Hematology & Oncology  (2015) 8:15 Page 10 of 12might account for the pronounced decreased prolifera-
tion of HSPCs. Finally, one recent report revealed that a
non-coding RNA arising from the CEBPA gene locus
could influence the methylation level of CEBPA promoter
by inhibiting DNMT1 protein binding to the regulatory
region of CEBPA gene [54], which also supported our
findings that Dnmt1 acts directly on cebpa promoter.
Taken together, our findings and others point out that
the regulation of C/ebpa function during hematopoiesis
takes place at multi-levels, including epigenetic modifi-
cation, transcriptional regulation, and post-translational
modification, which allow C/ebpa to exert its distin-
guished role in a fine-tuned manner.
Conclusions
Our studies for the first time clarify the possible molecu-
lar mechanism of Dnmt1 involved in HSPC maintenance
during definitive hematopoiesis in zebrafish. The fact
that C/ebpa functions as a critical downstream effector
of Dnmt1 provides new insights of Dnmt1-regulated
hematopoiesis.
Methods
Zebrafish maintenance and ENU mutagenesis
Zebrafish were maintained and staged under standard con-
ditions as described previously [55]. Zebrafish embryos
were cultured in “egg water” consisting of 0.03% sea salt
and 0.002% methylene blue. A 0.0045% 1-phenyl-2-thiourea
(Sigma-Aldrich, St. Louis, MO, USA) was used to prevent
melanization and facilitate in situ hybridization analysis of
gene expression [55]. ENU mutagenesis on Tubingen (Tu)
strain was carried out as described [56]. The WIK line was
used as the mapping strain. The zebrafish maintenance and
study protocols were approved by the Institutional Review
Board of the Institute of Health Sciences, Shanghai Insti-
tutes of Biological Sciences, Chinese Academy of Sciences
(Shanghai, China).
Whole-mount in situ hybridization (WISH)
Digoxigenin (DIG)-labeled RNA probes were synthesized
with T3 or T7 polymerase (Ambion, Life Technologies,
Carlsbad, CA, USA), using linearized cDNA plamid con-
structs. Whole-mount mRNA in situ hybridization was per-
formed as described previously [57]. The DIG-labeled
probes were detected using alkaline phosphatase-coupled
anti-digoxigenin Fab fragment antibody (Roche, Basel,
Switzerland) with BCIP/NBT staining (Vector Laboratories,
Burlingame, CA, USA).
Mapping and positional cloning of ldd794
ldd794 (Tu background) carrying the mutant allele were
outcrossed to the polymorphic wild-type strain WIK for
positional cloning. The genome for linked SSLP (simple
sequence length polymorphism) markers were scanned bybulk segregation analysis using standard methods [58].
For fine mapping, ldd794 mutant embryos were geno-
typed with SSLP markers to narrow down the genetic
interval. The cDNAs of candidate genes were sequenced
from pooled mutant RNA, and candidate mutation was
confirmed by sequencing the genomic DNA of individual
mutant embryo. All primers used for positional cloning
and dnmt1 sequencing are provided in Additional file 2.
Morpholinos and mRNA microinjection
Morpholinos (MOs) and mRNA were injected into em-
bryos at one-cell stage. Morpholino oligonucleotides were
designed by and ordered from Gene Tools. The morpho-
lino sequences are as follows: for dnmt1 MO, 5′-ACAAT
GAGGTCTTGGTAGGCATTTC-3′ (4 ng/embryo) [27];
and for dnmt1 splicing MO, 5′-CCACCCTTCAAAA
CAATAACAGTGT-3′ (8 ng/embryo). Capped mRNA
samples were transcribed from linearized plasmids
(mMessage Machine; Ambion), purified, and diluted to
100 ng/ul (dnmt1 and dnmt1 mutant mRNA) or 50 ng/ul
(SUMO2-C/ebpa and POZ-C/ebpa mRNA) for injection
of embryos at one-cell stage.
Anti-phosphorylated histone H3 (pH3) immunostaining
and TUNEL assay
Three days post-fertilization (dpf), Tg (cmyb:eGFP) em-
bryos were fixed in 4% paraformaldehyde (PFA). After
dehydration and rehydration, the embryos were treated
with Proteinase K (10 mg/ml) for 30 min at RT and re-
fixed in 4% PFA for 20 min. After blocking with blocking
buffer (2 mg/ml BSA+ 10% FBS + 0.3% Triton-X100 + 1%
DMSO in PBST), the embryos were stained with
mouse anti-GFP (Invitrogen, Carlsbad, CA, USA) and
rabbit anti-phosphohistone H3 antibody (Santa Cruz)
primary antibody at 4°C overnight. Alexa Fluor 488-
conjugated anti-mouse (Invitrogen) and Alexa Fluor
594-conjugated anti-rabbit (Invitrogen) were used as
secondary antibodies. Images were taken using Olym-
pus FV 1000 confocal microscopy equipped with the
FV10-ASW version 3 software.
Terminal transferase UTP nick end labeling (TUNEL)
was performed using the In Situ Cell Death Detection
Kit, TMR red (Roche), according to the manufacturer’s
recommendations.
Genomic DNA and RNA isolation
Tg (cmyb:EGFP) embryos at one-cell stage were
injected with dnmt1 ATG morpholino. Cells positive
for cmyb-EGFP were sorted and collected from homog-
enized embryos at 3 dpf. Genomic DNA (gDNA) and
total mRNA were extracted using the TRIzol reagent
(Life Technologies) according to the manufacturer’s
instructions.
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Reverse transcription was carried out using the super
script first-strand synthesis system (Life Technologies)
according to the manufacturer’s instructions. Real-time
quantitative PCR (Applied Biosystems, Foster City, CA,
USA) was used for relative quantification of cebpa gene
expression. The expression level of cebpa was normal-
ized to the expression of housekeeping gene GAPDH.
The primers used for real-time quantitative PCR were
listed in Additional file 2.Bisulfite sequencing PCR (BSP) assay
The DNA methylation assay was performed using the EZ
DNA Methylation Kit (Zymo Research, Irvine, CA, USA)
according to the manufacturer’s recommendations. The
treatment of DNA with bisulfite results in the selective
conversion of unmethylated cytosine to uracil, whereas
methylated cytosine remains unchanged. Methprimer
(http://www.urogene.org/methprimer/) was used to pre-
dict the CpG islands. The following primers were used for
bisulfite-specific polymerase chain reaction of the regula-
tion regions of the cebpa gene: BSP1 Fw: 5′-GTTTTATA
GAAGTTTGTTAGAGGGG-3′ and Rv: 5′-AACAAACC
CAACCCTTCTTTATTAT-3′; BSP2 Fw: 5′-TTTTTTT
TAGATGGTTTGTTTTAGG-3′ and Rv: 5′-ATAAATT
CACCCAAAAATTCAAAAC-3′; BSP3 Fw: 5′-TTTGA
TAATTAGTATGAATTGTTTTGTTTT-3′ and RV: 5′-
AACTTTAACCATATTATCCAAAATCACAT-3′; BSP4
Fw: 5′-ATATTTTTTGTGTAGATTTAAAATGGTGTT-
3′ and Rv: 5′-TACTCCATATAACACATTTAATCCAA
CTAA-3′. PCR products were subcloned into pMD18-T
Vector (Takara, Kyoto, Japan), and transformed bacteria
were cultured overnight. Clones (eight to ten) of each BSP
were sequenced for confirmation.Additional files
Additional file 1: Supplementary figures and figure legends.
Additional file 2: Table S1. The sequence information of SSLP markers,
dnmt1 sequencing primers, and Q-PCR primers.Abbreviations
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